Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02972385 · ClinicalTrials.gov registry record
Pharmacogenomics of Warfarin in Hispanics and Latinos
A clinical trial of Thrombosis and Hemorrhage, sponsored by University of Arizona.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT02972385 is a study of Thrombosis and Hemorrhage that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 400 participants, below the 456-participant average among 28 other Thrombosis trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02972385, a study of Thrombosis and Hemorrhage, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Warfarin is a commonly used blood thinner to treat and prevent blood clots. It is important to take the right dose of warfarin because too much can increase the risk of bleeding and too little can increase the risk of blood clots. This is why patients are closely monitored especially when they begin warfarin therapy. When clinicians prescribe warfarin, they have to consider different factors such as patient's age, body size, diet, and other medications that can interact with warfarin. Certain genes have also been found to affect warfarin dose. Individuals have variations in these genes, which can help explain why some patients need higher dose and others require less. These factors have been used to better predict a patient's warfarin dose requirement. However, these predictions were created based on Caucasian populations and they may not be accurate in predicting a safe warfarin dose if a patient is not Caucasian. This study aims to identify new genetic variation that affects warfarin dosing in Hispanic and Latino populations and try to better predict a Hispanic or Latino patient's warfarin dose requirement.
Conditions Studied
Interventions
- PROCEDURE Blood Draw
- PROCEDURE Mouthwash sample
Study Locations (1)
Arizona
- Banner University Medical Center - Tucson - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2016-09 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02972385
The ClinicalTrials.gov registry entry for NCT02972385 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 456-participant average among 28 other Thrombosis trials with a reported enrollment target (12% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Blood Draw is the first listed.
NCT02972385 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT02972385 about?
NCT02972385 is a clinical study titled "Pharmacogenomics of Warfarin in Hispanics and Latinos". Warfarin is a commonly used blood thinner to treat and prevent blood clots. It is important to take the right dose of warfarin because too much can increase the risk of bleeding and too little can increase the risk of blood clots. This is why patients are closely monitored especially when they begin...
What is the current status of trial NCT02972385?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2016-09. Estimated completion is 2026-09.
What conditions does trial NCT02972385 study?
This clinical trial studies the following conditions: Thrombosis, Hemorrhage.
What interventions are being tested in trial NCT02972385?
The interventions under investigation include: Blood Draw (PROCEDURE), Mouthwash sample (PROCEDURE).
Who is sponsoring clinical trial NCT02972385?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02972385 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
-
Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis
RECRUITING
-
Platelet Volunteers, Longitudinal and Multi-omic Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.